Web Results



Ixabepilone is an epothilone B analog developed by Bristol-Myers Squibb as a chemotherapeutic medication for cancer. It is produced by Sorangium cellulosum  ...

IXEMPRA® (ixabepilone) | Official patient site


Learn about IXEMPRA® (ixabepilone), including safety and boxed warning, side effects, benefits and risks, and dosing information.

Ixabepilone - National Cancer Institute


Nov 15, 2007 ... This page contains brief information about ixabepilone and a collection of links to more information about the use of this drug, research results, ...

Ixempra - Drug Information - Chemocare


Generic Name: Ixabepilone Ixempra is the trade name for the generic chemotherapy drug Ixabepilone. In some cases, health care professionals may use the ...

Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus ...


Jul 10, 2010 ... Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously ...

Ixabepilone | C27H42N2O5S - PubChem


Ixabepilone is an orally bioavailable semisynthetic analogue of epothilone B with antineoplastic activity. Ixabepilone binds to tubulin and promotes tubulin ...

DailyMed - IXEMPRA- ixabepilone


IXEMPRA (ixabepilone) is indicated in combination with capecitabine for the treatment of patients with metastatic or locally advanced breast cancer resistant to ...

Ixabepilone Injection: MedlinePlus Drug Information


Ixabepilone Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus.

Ixempra (Ixabepilone): Side Effects, Interactions, Warning, Dosage ...


Learn about Ixempra (Ixabepilone) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.

Ixabepilone: A Novel Antineoplastic Agent with Low Susceptibility to ...


Ixabepilone is an analogue of natural epothilone B with activity against a wide range of tumor types, including drug-resistant tumors. This is consistent with the ...

More Info

FDA Approval for Ixabepilone - National Cancer Institute


On October 16, 2007, the U.S. Food and Drug Administration (FDA) approved ixabepilone for injection (Ixempra™, made by Bristol-Myers Squibb) for the ...

Ixabepilone - Drug Information - Chemocare


Ixabepilone is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Ixabepilone is classified as an "antimicrotubule agent" or an "epothilone B ...

Ixempra (ixabepilone) - CenterWatch


Ixempra (ixabepilone): For the treatment of breast cancer. New approved drug details including side effects, uses and general information.